Continue current treatment: teriparatide
Treatment with PTH for 18–24 months has been studied. The beneficial effects of teriparatide on nonvertebral fractures have been shown to persist for up to 30 months after stopping teriparatide.
Literature
- Kanis JA, McCloskey EV, Johansson H, et al.
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013 Jan;24(1):23–57.
<%= buttons %>